Last updated on October 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)


Brief description of study

This prospective cohort study will provide information about: characteristics of Rivaroxaban use in patients who are prescribed Rivaroxaban for the first time compared to patients who are prescribed Acenocoumarol for the first time, the occurrence of intracranial haemorrhage, gastrointestinal and urogenital bleeding, and the occurrence of non-infective liver disease.

Clinical Study Identifier: NCT01947985

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Bayer Clinical Trials Contact

Many Locations, Netherlands
  Connect »